Advertisement

The Scientist

» biotech and disease/medicine

Most Recent

image: New African Bone Marrow Registry

New African Bone Marrow Registry

By | March 19, 2012

Nigeria launches its first ever bone marrow registry, which should make it easier to find matches for black people around the world.

0 Comments

image: HHMI Competition Opens

HHMI Competition Opens

By | March 16, 2012

The biomedical institute seeks up to 30 new investigators in its first nationwide search in 5 years.

0 Comments

image: Self-prescribing Patients?

Self-prescribing Patients?

By | March 13, 2012

The FDA considers making some drugs for diabetes, asthma, and other ailments available over the counter.

4 Comments

image: Trouble at the CDC?

Trouble at the CDC?

By | March 12, 2012

Anonymous letters to The Lancet point to problems with the CDC's Center for Global Health, but the agency denies the allegations.

4 Comments

image: High Tumor Heterogeneity Confirmed

High Tumor Heterogeneity Confirmed

By | March 9, 2012

One biopsy may not provide enough information about the array of mutations in cancer to devise treatments based on a tumor’s genetic profile.

2 Comments

image: Origami Sensors

Origami Sensors

By | March 9, 2012

An inexpensive 3-D paper sensor could test for HIV and malaria.

2 Comments

image: Opinion: On the Gene Patent Debate

Opinion: On the Gene Patent Debate

By | March 7, 2012

Two key patent cases that no doubt will impact the future of personalized medicine are pending review by the US Supreme Court. What will the Court decide?

18 Comments

image: H5N1 Insiders Speak Out

H5N1 Insiders Speak Out

By | March 6, 2012

NSABB and Congress members voice their opinions about the new developments in the H5N1 research debate.

0 Comments

image: Designer Aspirin Fights Cancer

Designer Aspirin Fights Cancer

By | March 5, 2012

Early experiments show that a hybrid form of the common pain reliever can effectively inhibit the growth of many tumor types.

0 Comments

image: Opinion: A Big Pharma Biotech Fund

Opinion: A Big Pharma Biotech Fund

By | March 5, 2012

Pharmaceutical companies should deploy cash to fund struggling biotech companies, which could generate much needed new drugs.

4 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement
RayBiotech
RayBiotech

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement
Life Technologies